Introduction {#Sec1}
============

Flexible bronchoscopy is used for diagnostic or therapeutic purposes of the airways or lung tissue. In general, bronchoscopy is a safe intervention with reported serious complications of 0.08% and mortality of 0.01% \[[@CR1]\]. Hypoxemia during or after bronchoscopy may occur as the result of ventilation/perfusion mismatch. Reduction in arterial oxygen pressure (PaO~2~) during bronchoscopy is \~7.7 mmHg \[[@CR2]\], but after bronchoalveolar lavage PaO~2~ may decrease by 23 mmHg \[[@CR3]\]. Ventilation/perfusion mismatch may persist 15--24 h \[[@CR4], [@CR5]\]. Such reduction in PaO~2~ does not carry significant risks for patients without pre-existent hypoxemia or cardiac disease and can be corrected by nasal oxygen supplementation. However, in patients with hypoxemia before bronchoscopy, further reduction in PaO~2~ may increase the risk of acute respiratory failure, cardiac ischemia and arrhythmias \[[@CR6]\]. Therefore, clinicians may be reluctant to perform diagnostic bronchoscopy in hypoxemic patients, in spite of the high diagnostic yield, even in critically ill patients \[[@CR7]\].

Few studies have investigated the role of non-invasive positive pressure ventilation (NPPV) to prevent hypoxemia during bronchoscopy. Antonelli et al. \[[@CR8]\] assessed the feasibility and safety of a full face mask to aid bronchoscopy during non-invasive ventilation. Maitre et al. \[[@CR9]\] have shown that continuous positive airway pressure (CPAP) during bronchoscopy in hypoxemic patients prevents oxygen desaturation and acute respiratory failure. However, in this latter study a specific CPAP device was needed, and it does not allow pressure support ventilation. We present a new NPPV face mask to aid bronchoscopy in hypoxemic patients.

Materials and methods {#Sec2}
=====================

Modified face mask {#Sec3}
------------------

A commercially available full face mask (Repironics^®^) was modified by the authors to allow introduction of the bronchoscope without interfering with the ventilator circuit. Accordingly, a plastic cylinder was secured in the mask at a position that allows introduction of bronchoscope through the mouth (Figs. [1](#Fig1){ref-type="fig"}, [2](#Fig2){ref-type="fig"}). A disposable cap (from a swivel connector) was used to seal the cylinder and prevent air leakage during bronchoscopy.Fig. 1Full face mask modified for the use of bronchoscopy during non-invasive positive pressure ventilation. A synthetic cylinder was secured in the mask. A disposable cap sealed the cylinder and prevented air leakage during bronchoscopyFig. 2Oral introduction of the flexible bronchoscope through the modified face mask during NPPV. Written permission for publication by patient

Study population {#Sec4}
----------------

The use of non-invasive mechanical ventilation during bronchoscopy in hypoxemic patients is the standard clinical practice in our hospital. Routine monitoring includes invasive blood pressure, peripheral oxygen saturation and heart rhythm. No additional measurements were performed for the current study. Therefore, formal approval for the current study was waived.

To demonstrate the feasibility of the modified face mask during diagnostic bronchoscopy 12 patients were prospectively analyzed. Non-ICU patients with indications for bronchoscopy and bronchoalveolar lavage, but reluctance of an experienced pulmonologist to perform this procedure because of hypoxemia or severe respiratory distress were included. Exclusion criteria are the recognized contraindications for NPPV, such as reduced level of consciousness, recent facial or esophageal surgery, and inability to tolerate the face mask.

Bronchoscopy {#Sec5}
------------

Patients were admitted to the ICU solely for the purpose of bronchoscopy. Patients refrained from oral intake, except water, for 6 h prior to the intervention. An arterial catheter was inserted into the radial artery for blood withdrawal and hemodynamic monitoring. All patients had venous access before ICU admission. Pulse-oximetry and heart rhythm (5-lead ECG) were continuously monitored.

Twenty minutes before bronchoscopy, patients were connected to NPPV to allow acclimatization. Positive end expiratory pressure (PEEP) was set at 6 cmH~2~O, pressure support 10 cmH~2~O and FiO~2~ 1.0. Topical anesthesia of the mouth and pharynx was achieved with xylocaine spray (10%). To this end the mask was briefly removed from the face. Additional xylocaine (1%) was administered through the bronchoscope as needed for topical aneasthesia of the vocal cords and trachea. The bronchoscope (Videoscope, Olympus^®^, diameter 4.9, 6.0 or 6.3 mm) was introduced via the plastic cylinder in the face mask (Fig. [2](#Fig2){ref-type="fig"}). Bronchoscopy and bronchoalveolar lavage were performed according to clinical protocols. After bronchoscopy, pressure support and FiO~2~ were tapered while maintaining oxygen saturation above 92%. When FiO~2~ was decreased to \~0.4, while patients maintained arterial oxygen saturation above 92% without respiratory distress, NPPV was discontinued. Oxygen was then supplemented through a non-rebreathing mask. Patients remained in the ICU for 12--24 h with continuously monitoring of SpO~2~ and heart rhythm. Arterial blood gasses were withdrawn before starting NPPV, during NPPV before and after bronchoscopy, and after discontinuing NPPV.

Results {#Sec6}
=======

Patient characteristics {#Sec7}
-----------------------

Patient characteristics are shown in Table [1](#Tab1){ref-type="table"}. Suspected infection was the most common reason for bronchoscopy. Only in patients 1 and 9 was bronchoscopy performed because of suspected interstitial lung disease. Except for patients 1, 9, 11 and 12, patients were immunocompromised at the time of bronchoscopy, either due to medication or recent stem cell transplantation. In one patient a low dose (50 mg/h) of propofol and in two patients a low dose of midazolam (2.5--7.0 mg) were administered during bronchoscopy because of agitation.Table 1Patient characteristics at baseline, oxygenation, time spent on ventilator and amount of lavage fluid injected and retrievedNo.Sex/age (years)Relevant medical historyPaO~2~ before NPPV (mmHg)/O~2~ (l/min)Lowest SpO~2~ (%)Time on NPPV (h)Lavage fluid in/out (ml)1F/69Myocardial infarction, renal failure76/594480/252F/62Non-Hodgkin lymphoma, pulmonary embolism,52/51004120/603M/57Polymyositis, CABG (5×)62/5997180/404M/58Aspiration pneumonia, secondary hyperparathyroidism, alcoholic gastritis83/4994180/1105F/48Multiple myeloma, allogeneic stem cell transplant, GvHD51/0100260/206M/75Non-Hodgkin lymphoma, prostatic carcinoma, CVA, spondylodiscitis65/3865180/507F/54Still disease, COPD65/51004150/508F/62Lymphoma, autologous stem cell transplantation,76/4963180/509F/73Coloncarcinoma T3N2Mx, polymyalgia rheumatic, angina pectoris85/2966180/4010M/76Kidney transplant, pulmonary embolism, sec. osteoporosis100/31004200/5011M/54Cerebral abscess, endocarditis, DM256/51006220/2012M/83Renal insufficiency, COPD49/59424100/30*F* Female, *M* male, *CABG* coronary artery bypass graft, *CVA* cerebral vascular accident, *COPD* chronic obstructive pulmonary disease, *DM2* diabetes mellitus type 2

As shown in Table [1](#Tab1){ref-type="table"}, all patients had severely impaired oxygen uptake before bronchoscopy at the general ward. The PaO~2~/FiO~2~ ratio before NPPV, during NPPV but before bronchoscopy and 1 h after bronchoscopy is shown in Fig. [3](#Fig3){ref-type="fig"}.Fig. 3PaO~2~/FiO~2~ ratio before initiation of NPPV, after 15 min of NPPV and after diagnostic bronchoscopy but during NPPV. \**P* \< 0.001 versus before NPPV and versus during NPPV, after bronchosocpy

Complications and outcome {#Sec8}
-------------------------

On average, patients were on NPPV for 6 h (range 2--24 h). All but two patients were transferred to the general ward within 24 h after ICU bronchoscopy.

In one patient SpO~2~ decreased to 86% during bronchoscopy (Table [1](#Tab1){ref-type="table"}). In this patient, the bronchoscope was briefly withdrawn to allow re-oxygenation. The procedure could be completed without subsequent complications. None of our patients showed arrhythmias or ST segment elevation/depression on five-lead ECG during or after the intervention.

Patient 2 could initially be weaned from NPPV within 2 h after bronchoscopy, and was well saturated with 5 l/min nasal O~2~ for several hours. However, his clinical condition deteriorated, requiring reinstitution of non-invasive ventilation and 28 h after bronchoscopy, endotracheal intubation. Culture of the lavage in this patient revealed *Pneumocystis jiroveci*.

In eight of the patients a causative infectious agent was found, including *Pneumocystis jiroveci*, *Streptococcus milleri*, *Streptococcus mitis*, *Rhinovirus* and *Enterobacter aerogenes*.

Discussion {#Sec9}
==========

Hypoxemia is a well-known contraindication for bronchoscopy \[[@CR6]\] due to the risk of acute respiratory failure, cardiac ischemia and arrhythmias during or after the intervention. Accordingly, in hypoxemic patients, physicians may either decline bronchoscopy or choose to intubate these patients to facilitate bronchoscopy. The current study shows that our modified face mask for NPPV is a feasible alternative for endotracheal intubation to facilitate bronchoscopy in a selection of these patients.

The feasibility of non-invasive ventilation to aid bronchoscopy has been published previously \[[@CR8], [@CR9]\]. These studies showed that non-invasive ventilation maintains oxygenation during bronchoscopy. Moreover, the study by Maitre et al. \[[@CR9]\] suggests that CPAP prevents acute respiratory failure, as indicated by fewer patients requiring endotracheal intubation within 6 h after procedure. However, the device to generate positive pressure used by Maitre and colleagues \[[@CR9]\] is not easily available and only allows CPAP. Our mask has several advantages compared to the devices used in the previous two studies on non-invasive ventilation during bronchoscopy \[[@CR8], [@CR9]\], such as the ability to deliver pressure support ventilation \[[@CR9]\], which seems reasonable during bronchoscopy to reduce the work of breathing. In addition, the increased distance between the mask and face of the patient allows better positioning of the bronchoscope, and the bronchoscope is not directly inserted into the ventilatory circuit. Finally, no specific equipment is required, and both nurses and intensive care staff are familiar with both the mask and ventilator used. Therefore, no special training is needed.

In our experience this mask can be used in all patients in whom hypoxemia could be reversed with non-invasive positive pressure ventilation. Indeed, we have used this mask to perform bronchoscopy with bronchoalveolar lavage in patients with PaO~2~ as low as 51 mmHg (without supplemental oxygen). In addition, the authors have used this mask to facilitate transbronchial biopsy in hypoxemic patients.

Nevertheless, several precautions should be considered. First, in these high-risk patients bronchoscopy should be performed by an experienced physician and in the presence of staff trained in emergency endotracheal intubation. Second, occasionally prolonged non-invasive ventilation is needed after bronchoscopy in these patients. Because of induction of shunt and possible inflammatory response due to lavage solution \[[@CR10]--[@CR12]\], approximately 24 h monitoring is recommended \[[@CR4], [@CR5]\]. Third, general contra-indications for non-invasive ventilation, including severe agitation and reduced level of consciousness, apply to our mask as well.

The safety of this mask has not been formally tested in a randomized trial, nor has the clinical outcome been assessed. To demonstrate the safety of our mask, hypoxemic patients with need for diagnostic bronchoscopy should be randomized to either bronchoscopy during non-invasive ventilation or after endotracheal intubation. As the authors have used this mask in over 75 patients without adverse events, it was felt unethical to perform such study. In addition, the value of bronchoalveolar lavage in obtaining a microbiological diagnosis, especially in immunocompromised patients, has been shown previously \[[@CR13]\].

In conclusion, the current paper presents a modified mask to facilitate diagnostic bronchoscopy during NPPV in hypoxemic patients.
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